Sergei Klebnikov, Forbes Staff

Author's posts

‘Pharma Bro’ Shkreli Plots Post-Jail NYC Return—Seeks Home In ‘Dope Building With Sick Views’

The notorious investor is reemerging from his prison sentence and back on social media.

Moderna Stock Falls Despite Vaccine Sales More Than Tripling From Last Year

Shares moved lower despite strong earnings results from the vaccine-maker.

Cannabis Stocks Are Surging Ahead Of House Vote On Marijuana Legalization Next Week

Sundial and Tilray are up about 50% but the gains may just be temporary.

Peloton Shares Fall After Major Outage Temporarily Hits Bikes And Treadmills

The outage lasted just over an hour before getting resolved, but shares fell on the news.

Peloton Shares Fall After New CEO Says Company Won’t Be Sold In The ‘Foreseeable Future’

Peloton’s new CEO, Barry McCarthy, pledged to double down on content and downplayed the possibility of a sale.

Can Peloton Be Saved? Here’s What Experts Say About The New CEO, Barry McCarthy

Shares of Peloton surged roughly 25% after Barry McCarthy was announced as the new CEO.

Apple, Amazon Or Nike? Peloton Stock Surges But Here’s What Experts Say About A Takeover

Wall Street loves to “ruminate” about potential M&A tech deals, and Peloton’s potential takeover is the latest focus of investor chatter.

Here Are The Biggest Losing Stocks In The Market’s Worst Month Since March 2020

Some of the pandemic’s hottest stocks are among the worst performers so far in 2022.

Here’s Why Airline Stocks Are Rising Despite The Flight Cancellation Nightmare

Shares of major airlines like Delta, United and American jumped to kick off 2022.

Over 3,000 Canceled Flights: Airline Cuts Continue As Covid Cases Rise, Staff Shortages Persist

Fauci suggests vaccine mandates may be needed for domestic air travel.